药物对比
Galcanezumab vs Lasmiditan
比较 Galcanezumab (Emgality) 与 Lasmiditan (Reyvow) 在偏头痛治疗方面的应用。Galcanezumab 是靶向CGRP的预防性单克隆抗体,而 Lasmiditan 是作用于5-HT1F受体的急性口服药物。根据您的偏头痛模式进行选择——频繁发作适合 galcanezumab,急性发作适合 lasmiditan。请咨询医生以获取个性化建议。
此页面暂无可用的对比维度。
临床背景
Patients deciding between a preventive CGRP monoclonal antibody and an acute oral 5-HT1F receptor agonist for migraine management.
结论
Both Galcanezumab and Lasmiditan are effective migraine treatments but serve different purposes, with galcanezumab for prevention and lasmiditan for acute attacks.
全部药物对比